These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 31166288

  • 1. Does an Antimicrobial Time-Out Impact the Duration of Therapy of Antimicrobials in the PICU?
    Adams SM, Ngo L, Morphew T, Babbitt CJ.
    Pediatr Crit Care Med; 2019 Jun; 20(6):560-567. PubMed ID: 31166288
    [Abstract] [Full Text] [Related]

  • 2. Antimicrobial consumption in five adult intensive care units: a 33-month surveillance study.
    Balkhy HH, El-Saed A, El-Metwally A, Arabi YM, Aljohany SM, Al Zaibag M, Baharoon S, Alothman AF.
    Antimicrob Resist Infect Control; 2018 Jun; 7():156. PubMed ID: 30598819
    [Abstract] [Full Text] [Related]

  • 3. Increased Risk of Acute Kidney Injury in Critically Ill Children Treated With Vancomycin and Piperacillin/Tazobactam.
    Holsen MR, Meaney CJ, Hassinger AB, Fusco NM.
    Pediatr Crit Care Med; 2017 Dec; 18(12):e585-e591. PubMed ID: 28906422
    [Abstract] [Full Text] [Related]

  • 4. Incidence of Acute Kidney Injury Among Patients Receiving the Combination of Vancomycin with Piperacillin-Tazobactam or Meropenem.
    Robertson AD, Li C, Hammond DA, Dickey TA.
    Pharmacotherapy; 2018 Dec; 38(12):1184-1193. PubMed ID: 30175410
    [Abstract] [Full Text] [Related]

  • 5. Rates and appropriateness of antimicrobial prescribing at an academic children's hospital, 2007-2010.
    Levy ER, Swami S, Dubois SG, Wendt R, Banerjee R.
    Infect Control Hosp Epidemiol; 2012 Apr; 33(4):346-53. PubMed ID: 22418629
    [Abstract] [Full Text] [Related]

  • 6. Point prevalence survey of antimicrobial utilization in the cardiac and pediatric critical care unit.
    Blinova E, Lau E, Bitnun A, Cox P, Schwartz S, Atenafu E, Yau Y, Streitenberger L, Parshuram CS, Marshall J, Seto W.
    Pediatr Crit Care Med; 2013 Jul; 14(6):e280-8. PubMed ID: 23823209
    [Abstract] [Full Text] [Related]

  • 7. [Risk of Acute Kidney Injury in Patients Treated with Vancomycin and Piperacillin/Tazobactam Compared to Vancomycin and Meropenem or Doripenem: A Retrospective Cohort Study].
    Ide N, Sato S, Sawaguchi K.
    Yakugaku Zasshi; 2019 Jul; 139(12):1609-1614. PubMed ID: 31787651
    [Abstract] [Full Text] [Related]

  • 8. OTAC: Optimization of Antibiotic Therapy in Critically ill Patients. Using beta-lactam antibiotics by continuous infusion.
    Esteve-Pitarch E, Padullés-Zamora A, Maisterra-Santos K, Colom-Codina H, Cobo-Sacristán S.
    Farm Hosp; 2019 Sep 01; 43(5):151-157. PubMed ID: 31469627
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Association of Acute Kidney Injury With Concomitant Vancomycin and Piperacillin/Tazobactam Treatment Among Hospitalized Children.
    Downes KJ, Cowden C, Laskin BL, Huang YS, Gong W, Bryan M, Fisher BT, Goldstein SL, Zaoutis TE.
    JAMA Pediatr; 2017 Dec 04; 171(12):e173219. PubMed ID: 28973124
    [Abstract] [Full Text] [Related]

  • 11. Retrospective evaluation of piperacillin-tazobactam, imipenem-cilastatin and meropenem used on surgical floors at a tertiary care hospital in Saudi Arabia.
    Youssif E, Aseeri M, Khoshhal S.
    J Infect Public Health; 2018 Dec 04; 11(4):486-490. PubMed ID: 29153444
    [Abstract] [Full Text] [Related]

  • 12. Effect of concomitant vancomycin and piperacillin-tazobactam on frequency of acute kidney injury in pediatric patients.
    Buhlinger KM, Fuller KA, Faircloth CB, Wallace JR.
    Am J Health Syst Pharm; 2019 Aug 01; 76(16):1204-1210. PubMed ID: 31369115
    [Abstract] [Full Text] [Related]

  • 13. Comparison of teicoplanin versus vancomycin in combination with piperacillin-tazobactam or meropenem for the risk of acute kidney injury.
    Aslan AT, Pashayev T, Dağ O, Akova M.
    Eur J Clin Microbiol Infect Dis; 2021 Sep 01; 40(9):1953-1961. PubMed ID: 33884515
    [Abstract] [Full Text] [Related]

  • 14. Formalization of an antimicrobial stewardship program in a small community hospital.
    Lockwood AR, Bolton NS, Winton MD, Carter JT.
    Am J Health Syst Pharm; 2017 Sep 01; 74(17 Supplement 3):S52-S60. PubMed ID: 28842518
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the Nephrotoxicity of Vancomycin in Combination With Cefepime, Meropenem, or Piperacillin/Tazobactam: A Prospective, Multicenter Study.
    Mullins BP, Kramer CJ, Bartel BJ, Catlin JS, Gilder RE.
    Ann Pharmacother; 2018 Jul 01; 52(7):639-644. PubMed ID: 29442542
    [Abstract] [Full Text] [Related]

  • 16. Reduction of Inappropriate Antimicrobial Prescriptions in a Tertiary Neonatal Intensive Care Unit After Antimicrobial Stewardship Care Bundle Implementation.
    Ting JY, Paquette V, Ng K, Lisonkova S, Hait V, Shivanada S, Tilley P, Osiovich H, Roberts A.
    Pediatr Infect Dis J; 2019 Jan 01; 38(1):54-59. PubMed ID: 30531528
    [Abstract] [Full Text] [Related]

  • 17. Acute kidney injury with combination vancomycin and piperacillin-tazobactam therapy in the ICU: A retrospective cohort study.
    O'Callaghan K, Hay K, Lavana J, McNamara JF.
    Int J Antimicrob Agents; 2020 Jul 01; 56(1):106010. PubMed ID: 32413387
    [Abstract] [Full Text] [Related]

  • 18. Reduction of Broad-Spectrum Antimicrobial Use in a Tertiary Children's Hospital Post Antimicrobial Stewardship Program Guideline Implementation.
    Lee KR, Bagga B, Arnold SR.
    Pediatr Crit Care Med; 2016 Mar 01; 17(3):187-93. PubMed ID: 26669645
    [Abstract] [Full Text] [Related]

  • 19. Shifts in antimicrobial consumption and infection rates before and during a piperacillin/tazobactam shortage.
    King ST, Barber KE, Parham JJ, Stover KR.
    J Glob Antimicrob Resist; 2017 Dec 01; 11():111-113. PubMed ID: 28774865
    [Abstract] [Full Text] [Related]

  • 20. Bloodstream Infections in Children With Cancer: Pathogen Distribution and Antimicrobial Susceptibility Patterns Over a 10-Year Period.
    Maarbjerg SF, Kiefer LV, Albertsen BK, Schrøder H, Wang M.
    J Pediatr Hematol Oncol; 2022 Jan 01; 44(1):e160-e167. PubMed ID: 34310474
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.